XXII Group Revenue and Competitors

SURESNES,

Location

#6743

Growjo Ranking

Analytics

Industry

Estimated Revenue & Valuation

  • XXII Group's estimated annual revenue is currently $59.1M per year.(i)
  • XXII Group's estimated revenue per employee is $175,000

Employee Data

  • XXII Group has 338 Employees.(i)
  • XXII Group grew their employee count by 65% last year.

XXII Group's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head Recruitment & Employer Brand / HRReveal Email/Phone
3
VP, AI OrchestrationReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19370M267721%$10M$128.9B
Add Company

What Is XXII Group?

VISION IS THE FOUNDATION OF HUMAN INTELLIGENCE XXII is the story of two childhood friends, William Eldin (CEO) and Dam Mulhem (CDO). The startup very quickly met a skyrocketing growth, making revenues on its own after only 6 months of activity, and hiring around 50 PhDs, engineers, developers and creatives. Today, XXII is made of talents from all backgrounds and specialties, building tomorrow's vision and tools. XXII specialises in Computer Vision, including Artificial Intelligence, Virtual and Augmented Reality. Our AIaaS (AI as a Service) platform provides ROI-oriented real-time video analysis solutions for security, retail and industries. Our VR and AR training, simulation and maintenance tools allow data visualisation in real-time, as well as immersive and safe training situations. Our clients include: Enedis, GRT Gaz, Airbus, Chimex, Renault, Air France, Groupe Casino, Galeries Lafayette, Sephora, etc. INTELLIGENCE IS THE FOUNDATION OF HUMAN EVOLUTION

keywords:N/A

N/A

Total Funding

338

Number of Employees

$59.1M

Revenue (est)

65%

Employee Growth %

N/A

Valuation

N/A

Accelerator

XXII Group News

2022-04-20 - 22nd Century Group (Nasdaq: XXII) Issues Annual Letter to ...

BUFFALO, N.Y., April 28, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company...

2022-04-19 - 22nd Century Group (Nasdaq: XXII) to Participate in AGP ...

BUFFALO, N.Y., April 27, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company...

2022-04-19 - 22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partner’s Virtual Spring Consumer Cannabis Conference

22nd Century Group, Inc. (Nasdaq: XXII) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$123.7M40432%N/A
#2
$144.9M4732%N/A
#3
$210.6M10487%N/A
#4
$484.5M10786%N/A